| pubmed-article:17107250 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17107250 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:17107250 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:17107250 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
| pubmed-article:17107250 | lifeskim:mentions | umls-concept:C0073393 | lld:lifeskim |
| pubmed-article:17107250 | lifeskim:mentions | umls-concept:C0332189 | lld:lifeskim |
| pubmed-article:17107250 | lifeskim:mentions | umls-concept:C0171023 | lld:lifeskim |
| pubmed-article:17107250 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:17107250 | pubmed:dateCreated | 2006-11-19 | lld:pubmed |
| pubmed-article:17107250 | pubmed:abstractText | The efficacy and safety of switching to olanzapine were investigated in patients with first-episode schizophrenia who failed to attain an adequate clinical response to an initial therapeutic trial of risperidone (2-6 mg/day for 12 weeks). | lld:pubmed |
| pubmed-article:17107250 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17107250 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17107250 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17107250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17107250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17107250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17107250 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17107250 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17107250 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:17107250 | pubmed:issn | 1555-2101 | lld:pubmed |
| pubmed-article:17107250 | pubmed:author | pubmed-author:IshigookaJunJ | lld:pubmed |
| pubmed-article:17107250 | pubmed:author | pubmed-author:TakahashiHito... | lld:pubmed |
| pubmed-article:17107250 | pubmed:author | pubmed-author:YoshidaKeizoK | lld:pubmed |
| pubmed-article:17107250 | pubmed:author | pubmed-author:KamataMitsuhi... | lld:pubmed |
| pubmed-article:17107250 | pubmed:author | pubmed-author:HiguchiHisash... | lld:pubmed |
| pubmed-article:17107250 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17107250 | pubmed:volume | 67 | lld:pubmed |
| pubmed-article:17107250 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17107250 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17107250 | pubmed:pagination | 1577-82 | lld:pubmed |
| pubmed-article:17107250 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:meshHeading | pubmed-meshheading:17107250... | lld:pubmed |
| pubmed-article:17107250 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:17107250 | pubmed:articleTitle | Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial. | lld:pubmed |
| pubmed-article:17107250 | pubmed:affiliation | Yuri Kumiai General Hospital, Honjoh, Akita, Japan. takahashi_h1969@yahoo.co.jp | lld:pubmed |
| pubmed-article:17107250 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17107250 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:17107250 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17107250 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17107250 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17107250 | lld:pubmed |
